|
FOR IMMEDIATE RELEASE
Unbound Medicine and Tarius Launch
21 CFR Handheld
Regulations and Updated Federal Register now
on
PDAs and Wireless Devices
Charlottesville, VA and Albertslund, Denmark,
November 16, 2005 — Today, Unbound Medicine,
the leading provider of authoritative information designed for mobile
professionals, and Tarius, the leading provider
of global regulatory and compliance information for the pharmaceutical
industry, announced the release of 21 CFR Handheld. Mobile regulatory
professionals can now consult the complete Title 21 of the Code
of the Federal Regulations (CFR) as well as Federal Register updates
from any location using either a personal digital assistant (PDA)
or a wireless device such as BlackBerry, Treo, or a Smartphone.
Regulatory and quality assurance professionals frequently consult
current and relevant regulatory information to guide their decision
making. Traditionally, these professionals carry a book of regulations
with them and add notes manually whenever a change occurs. The book
itself is only updated annually, so they must check regularly for
updates and rely on their own notes in order to remain current.
For 21 CFR Handheld, Tarius inserts links that connect the user
to amendments within hours of the daily release of new information
by the U.S. Government Printing Office. Unbound Medicine’s
unique platform delivers this daily update to 21 CFR Handheld users,
either through PDA synchronization or over the Internet to a wireless
device. Now regulatory professionals can always have the most up-to-date
information in an integrated and portable format. .
“On-the-go pharmaceutical and regulatory professionals who
need fast, authoritative answers to the constantly changing regulations
that govern human drugs, biologics and medical devices will now
be able to check the complete 21 CFR from any location, “
said Bill Detmer, MD, President and CEO of Unbound Medicine. “We
are proud to partner with Tarius to serve this segment of the healthcare
market, given their global reputation as a source of high quality
information.”
“Unbound Medicine’s strength in information architecture
and their versatile technology are a perfect complement to our capabilities
at Tarius,” said Nina Lindholst, Vice President of Tarius.
“Now our users can carry the essential 21 CFR in their pockets—complete
with bi-directional links to the latest amendments.”
For more information about 21 CFR Handheld visit Unbound
Medicine's Online Catalog or CFR
Handheld website.
About Tarius A/S
Tarius is the leading provider of global regulatory and compliance
information for the pharmaceutical industry. Tarius continuously
monitors information published by national authorities in more than
50 countries to provide companies in Europe and North America with
online databases and customized, confidential intelligence solutions.
Tarius is a wholly owned subsidiary of the Schultz Group, which
was founded in 1661. Schultz is one of Denmark's largest publishing
houses and is Denmark’s Government Printing Office. Schultz
serves professional customers with a broad array of databases, printed
materials, web portals and subscription-based services in all legal
fields. Additional information is available at www.tarius.com.
About Unbound Medicine
Unbound Medicine, Inc. develops next-generation knowledge management
systems for healthcare. The company’s handheld, wireless and
Web-based technology platform and information architecture services
help partners provide clinicians, researchers, and other healthcare
and regulatory professionals with advanced systems for acquiring,
managing, and sharing knowledge. Additional information is available
at www.unboundmedicine.com.
# # #
For Further Information Contact:
Paul Stadter
Unbound Medicine
1-610-627-9090 x227
Nina Lindholst, Vice President, Tarius
Telephone: +45 43 22 73 90
|